Files in this Data Supplement:
Tables S1 (Patient and specimen characteristics for the clinical plasma samples tested in this study), S2 (Distribution of primer pairs in the primer half-plate of the integrated fluidic circuit of the Access Array), S3 (UL54 mutations that have been confirmed phenotypically and were considered accepted drug resistance mutations in this study), and S4 (UL97 mutations that have been confirmed phenotypically and were considered accepted drug resistance mutations in this study) and Fig. S1 (Visualization of long-range PCR amplification products), S2 (Average read coverage per nucleotide when 24 or 8 specimens are sequenced), and S3 (Read coverage per amplicon in the forward and reverse sequencing directions)
PDF, 724K